Retroviral_NN
mediated_VBD
transfer_NN
and_CC
expression_NN
of_IN
exogenous_JJ
genes_NNS
in_IN
primary_JJ
lymphoid_JJ
cells_NNS
:_:
assaying_VBG
for_IN
a_DT
viral_JJ
transactivator_NN
activity_NN
in_IN
normal_JJ
and_CC
malignant_JJ
cells_NNS
._.

In_IN
this_DT
report_NN
we_PRP
describe_VBP
the_DT
use_NN
of_IN
recombinant_JJ
retroviruses_NNS
to_TO
characterize_VB
the_DT
activity_NN
of_IN
an_DT
exogenous_JJ
promoter_NN
in_IN
primary_JJ
cells_NNS
obtained_VBN
from_IN
patients_NNS
with_IN
lymphoproliferative_JJ
disorders_NNS
._.

The_DT
infection_NN
of_IN
a_DT
variety_NN
of_IN
cultured_VBN
and_CC
primary_JJ
lymphoid_JJ
cells_NNS
with_IN
a_DT
recombinant_JJ
retrovirus_NN
containing_VBG
a_DT
histone_NN
promoter-driven_JJ
beta-galactosidase_NN
gene_NN
is_VBZ
shown_VBN
to_TO
result_VB
in_IN
the_DT
expression_NN
of_IN
beta-galactosidase_NN
in_IN
50_CD
%_NN
to_TO
100_CD
%_NN
of_IN
the_DT
cells_NNS
._.

A_DT
similar_JJ
infection_NN
with_IN
a_DT
recombinant_JJ
retrovirus_NN
containing_VBG
the_DT
beta-galactosidase_NN
gene_NN
with_IN
an_DT
adenovirus_NN
E2_NN
promoter_NN
,_,
results_VBZ
in_IN
beta-galactosidase_NN
activity_NN
in_IN
a_DT
limited_JJ
number_NN
of_IN
cultured_VBN
and_CC
primary_JJ
cells_NNS
._.

Since_IN
the_DT
adenovirus_NN
E2_NN
promoter_NN
has_VBZ
been_VBN
well_RB
characterized_VBN
and_CC
is_VBZ
known_VBN
to_TO
be_VB
regulated_VBN
by_IN
transactivators_NNS
encoded_VBN
by_IN
many_JJ
viruses_NNS
,_,
the_DT
activity_NN
of_IN
this_DT
promoter_NN
in_IN
specific_JJ
cell_NN
types_NNS
is_VBZ
discussed_VBN
in_IN
reference_NN
to_TO
both_CC
the_DT
biology_NN
of_IN
the_DT
cell_NN
and_CC
the_DT
possible_JJ
presence_NN
of_IN
as_IN
yet_RB
undetected_JJ
viral_JJ
gene_NN
products_NNS
._.

